Ligand · WMH
WMH · 1-methyl-1H-1,2,3-triazole
WMH, 1-methyl-1H-1,2,3-triazole (C3 H5 N3, 83.1 g/mol), in the MolNFT structures on GenesisL1: bound in 10 records (7 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.
- Component
- WMH
- Formula
- C3 H5 N3
- Class
- ligand
- Structures
- 10
- PDB entries
- 7
Binding sites
WMH in 10 structures; the first of them:
- 6U22 · Crystal structure of SFTI-triazole inhibitor in complex with beta-trypsin · WMH C101 · binds GLY1, ARG2, ALA3, THR4, PRO9, ILE10, ALA11, PHE12
- 6U24 · NMR solution structure of triazole bridged SFTI-1 · WMH A101 · binds ARG2, ALA3, THR4, PRO9, ILE10, ALA11
- 6U7W · NMR solution structure of a triazole bridged KLK7 inhibitor · WMH A101 · binds LYS2, ALA3, LEU4, PHE5, PRO9, ILE10, ALA11
- 6Q1U · Structure of plasmin and peptide complex · WMH C101 · binds GLY1, ARG2, ALA3, PRO9, ILE10, ALA11
- 6U22 · Crystal structure of sfti-triazole inhibitor in complex with beta- trypsin · WMH C101 · binds GLY1, ARG2, ALA3, PRO9, ILE10, ALA11
- 6U24 · NMR solution structure of triazole bridged sfti-1 · WMH A101 · binds ARG2, ALA3, PRO9, ILE10, ALA11
- 6U7U · NMR solution structure of triazole bridged matriptase inhibitor · WMH A101 · binds ARG2, ALA3, PRO9, ARG10, ALA11
- 6U7W · NMR solution structure of a triazole bridged KLK7 inhibitor · WMH A101 · binds LYS2, ALA3, PHE5, PRO9, ILE10, ALA11
- 6U7X · NMR solution structure of triazole bridged plasmin inhibitor · WMH A101 · binds ALA3, PRO9, ILE10, ALA11
- 6VXY · Triazole bridged SFTI1 inhibitor in complex with beta-trypsin · WMH C101 · binds GLY216, GLY219, GLY1, ARG2, GLY3, THR4, ILE10, ALA11 and 1 more
Residues it binds most
ALA 11, ILE 10, PRO 10, ARG 8, GLY 5, PHE 4, THR 3, LYS 2, LEU 1 (residue and the binding sites it lines).
Found with
- CA · Calcium ion
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.